Fanyuan Zeng YOU? Author Swipe

Last 10y

770 Immune landscape of cardiovascular mortality in primary prostate cancer patients following leuprolide treatment, a non-canonical immunotherapy Open

Tuisha Gupta, Yujie Chen, Fanyuan Zeng, Maggie Li, Ganesh R. Talekar , et al. · 2025

Targeting the VIP-VPAC Pathway in Melanoma Models Inhibits Tumor Growth and Liver Metastasis Open

Wenxi Wang, Hua Yang, Tenzin Passang, Yiwen Li, Hanwen Zhang , et al. · 2025

Uveal melanoma (UVM) is resistant to immune checkpoint therapy and chemotherapy, resulting in high mortality rates, primarily due to liver metastases. While vasoactive intestinal peptide (VIP) signaling has been identified as an immune che…

732 Vasoactive intestinal peptide (VIP) increases during tumor ontology in KPC GEMM mice Open

Shayna Jankowski, Shuhua Wang, Tenzin Passang, Fanyuan Zeng, Edmund K. Waller · 2024

1347 VIP Biology drive prognosis in AML patients Open

Fanyuan Zeng, Yuou Wang, Kiranj Chaudagar, Jianming Li, Edmund K. Waller · 2024

Figure S1 from VPAC2 Receptor Signaling Promotes Growth and Immunosuppression in Pancreatic Cancer Open

Tenzin Passang, Shuhua Wang, Hanwen Zhang, Fanyuan Zeng, Po-Chih Hsu , et al. · 2024

Supplementary Figure

Figure S4 from VPAC2 Receptor Signaling Promotes Growth and Immunosuppression in Pancreatic Cancer Open

Tenzin Passang, Shuhua Wang, Hanwen Zhang, Fanyuan Zeng, Po-Chih Hsu , et al. · 2024

Supplementary Figure

Figure S6 from VPAC2 Receptor Signaling Promotes Growth and Immunosuppression in Pancreatic Cancer Open

Tenzin Passang, Shuhua Wang, Hanwen Zhang, Fanyuan Zeng, Po-Chih Hsu , et al. · 2024

Supplementary Figure

Supplementary Methods and Materials from VPAC2 Receptor Signaling Promotes Growth and Immunosuppression in Pancreatic Cancer Open

Tenzin Passang, Shuhua Wang, Hanwen Zhang, Fanyuan Zeng, Po-Chih Hsu , et al. · 2024

Supplementary Methods and Materials

Data from VPAC2 Receptor Signaling Promotes Growth and Immunosuppression in Pancreatic Cancer Open

Tenzin Passang, Shuhua Wang, Hanwen Zhang, Fanyuan Zeng, Po-Chih Hsu , et al. · 2024

Pancreatic ductal adenocarcinoma (PDAC) harbors a complex tumor microenvironment, and cross-talk among cells in the tumor microenvironment can contribute to drug resistance and relapse. Vasoactive intestinal peptide (VIP) is overexpressed …

Figure S3 from VPAC2 Receptor Signaling Promotes Growth and Immunosuppression in Pancreatic Cancer Open

Tenzin Passang, Shuhua Wang, Hanwen Zhang, Fanyuan Zeng, Po-Chih Hsu , et al. · 2024

Supplementary Figure

Figure S2 from VPAC2 Receptor Signaling Promotes Growth and Immunosuppression in Pancreatic Cancer Open

Tenzin Passang, Shuhua Wang, Hanwen Zhang, Fanyuan Zeng, Po-Chih Hsu , et al. · 2024

Supplementary Figure

Figure S1 from VPAC2 Receptor Signaling Promotes Growth and Immunosuppression in Pancreatic Cancer Open

Tenzin Passang, Shuhua Wang, Hanwen Zhang, Fanyuan Zeng, Po-Chih Hsu , et al. · 2024

Supplementary Figure

Supplementary Methods and Materials from VPAC2 Receptor Signaling Promotes Growth and Immunosuppression in Pancreatic Cancer Open

Tenzin Passang, Shuhua Wang, Hanwen Zhang, Fanyuan Zeng, Po-Chih Hsu , et al. · 2024

Supplementary Methods and Materials

Figure S6 from VPAC2 Receptor Signaling Promotes Growth and Immunosuppression in Pancreatic Cancer Open

Tenzin Passang, Shuhua Wang, Hanwen Zhang, Fanyuan Zeng, Po-Chih Hsu , et al. · 2024

Supplementary Figure

Figure S3 from VPAC2 Receptor Signaling Promotes Growth and Immunosuppression in Pancreatic Cancer Open

Tenzin Passang, Shuhua Wang, Hanwen Zhang, Fanyuan Zeng, Po-Chih Hsu , et al. · 2024

Supplementary Figure

Figure S2 from VPAC2 Receptor Signaling Promotes Growth and Immunosuppression in Pancreatic Cancer Open

Tenzin Passang, Shuhua Wang, Hanwen Zhang, Fanyuan Zeng, Po-Chih Hsu , et al. · 2024

Supplementary Figure

Figure S5 from VPAC2 Receptor Signaling Promotes Growth and Immunosuppression in Pancreatic Cancer Open

Tenzin Passang, Shuhua Wang, Hanwen Zhang, Fanyuan Zeng, Po-Chih Hsu , et al. · 2024

Supplementary Figure

Data from VPAC2 Receptor Signaling Promotes Growth and Immunosuppression in Pancreatic Cancer Open

Tenzin Passang, Shuhua Wang, Hanwen Zhang, Fanyuan Zeng, Po-Chih Hsu , et al. · 2024

Pancreatic ductal adenocarcinoma (PDAC) harbors a complex tumor microenvironment, and cross-talk among cells in the tumor microenvironment can contribute to drug resistance and relapse. Vasoactive intestinal peptide (VIP) is overexpressed …

Figure S5 from VPAC2 Receptor Signaling Promotes Growth and Immunosuppression in Pancreatic Cancer Open

Tenzin Passang, Shuhua Wang, Hanwen Zhang, Fanyuan Zeng, Po-Chih Hsu , et al. · 2024

Supplementary Figure

Figure S4 from VPAC2 Receptor Signaling Promotes Growth and Immunosuppression in Pancreatic Cancer Open

Tenzin Passang, Shuhua Wang, Hanwen Zhang, Fanyuan Zeng, Po-Chih Hsu , et al. · 2024

Supplementary Figure

VPAC2 Receptor Signaling Promotes Growth and Immunosuppression in Pancreatic Cancer Open

Tenzin Passang, Shuhua Wang, Hanwen Zhang, Fanyuan Zeng, Po-Chih Hsu , et al. · 2024

Pancreatic ductal adenocarcinoma (PDAC) harbors a complex tumor microenvironment, and cross-talk among cells in the tumor microenvironment can contribute to drug resistance and relapse. Vasoactive intestinal peptide (VIP) is overexpressed …

CT-based peritumoral radiomics nomogram on prediction of response and survival to induction chemotherapy in locoregionally advanced nasopharyngeal carcinoma Open

Fanyuan Zeng, Zhuomiao Ye, Qin Zhou · 2024

Purpose The study aims to harness the value of radiomics models combining intratumoral and peritumoral features obtained from pretreatment CT to predict treatment response as well as the survival of LA-NPC(locoregionally advanced nasophary…

VPAC2 receptor signaling promotes pancreatic cancer cell growth and decreases the immunogenicity of the tumor microenvironment Open

Tenzin Passang, Shuhua Wang, Hanwen Zhang, Fanyuan Zeng, Po-Chih Hsu , et al. · 2024

Identifying mechanisms underlying tumor growth and immune resistance is needed to treat pancreatic ductal adenocarcinoma (PDAC) effectively. The complexity of the tumor microenvironment (TME) suggests that the crosstalk between cells in th…

A cost-effectiveness analysis of toripalimab plus TP versus TP for the first-line treatment of advanced esophageal cancer Open

Fanyuan Zeng, Zhuo-miao Ye, Hao-lun Wang, Zhe Xu, Qin Zhou , et al. · 2022

Objective : We evaluated the cost-effectiveness of Toripalimab plus TP in treating patients with esophageal cancer in this study. Perspective : the Chinese payers. Methods : A Markov model was developed from the Chinese payers’ perspective…

The interplay of circulating tumor DNA and chromatin modification, therapeutic resistance, and metastasis Open

Lei Zhang, Yiyi Liang, Shifu Li, Fanyuan Zeng, Yongan Meng , et al. · 2019

Peripheral circulating free DNA (cfDNA) is DNA that is detected in plasma or serum fluid with a cell-free status. For cancer patients, cfDNA not only originates from apoptotic cells but also from necrotic tumor cells and disseminated tumor…

Fetching topic information...